• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Risk prediction and clinical model building for lymph node metastasis in papillary thyroid microcarcinoma.甲状腺微小乳头状癌淋巴结转移的风险预测与临床模型构建
Onco Targets Ther. 2016 Aug 24;9:5307-16. doi: 10.2147/OTT.S107913. eCollection 2016.
2
The analysis of clinicopathologic predictors of lymph node metastasis and postoperative recurrence in patients with papillary thyroid microcarcinoma from Guangdong Province, China-a multicenter retrospective study.中国广东省甲状腺微小乳头状癌患者淋巴结转移及术后复发的临床病理预测因素分析——一项多中心回顾性研究
Int J Clin Exp Pathol. 2017 Sep 1;10(9):9735-9743. eCollection 2017.
3
Lateral lymph node metastasis in papillary thyroid microcarcinoma: a study of 5241 follow-up patients.甲状腺微小乳头状癌侧颈部淋巴结转移:5241 例随访患者研究。
Endocrine. 2024 Feb;83(2):414-421. doi: 10.1007/s12020-023-03486-5. Epub 2023 Aug 18.
4
Clinical and pathologic predictors of lymph node metastasis in papillary thyroid microcarcinomas.甲状腺微小乳头状癌中淋巴结转移的临床和病理预测因素。
Ann Diagn Pathol. 2020 Dec;49:151647. doi: 10.1016/j.anndiagpath.2020.151647. Epub 2020 Oct 22.
5
Clinicopathological features for predicting central and lateral lymph node metastasis in papillary thyroid microcarcinoma: Analysis of 66 cases that underwent central and lateral lymph node dissection.预测甲状腺微小乳头状癌中央区和侧方淋巴结转移的临床病理特征:对66例行中央区和侧方淋巴结清扫病例的分析
Mol Clin Oncol. 2017 Jan;6(1):49-55. doi: 10.3892/mco.2016.1085. Epub 2016 Nov 18.
6
Predictive factors of lateral lymph node metastasis in solitary papillary thyroid microcarcinoma without gross extrathyroidal extension.不伴有甲状腺外侵犯的单发微小乳头状甲状腺癌侧颈部淋巴结转移的预测因素。
Asian J Surg. 2019 Apr;42(4):563-570. doi: 10.1016/j.asjsur.2018.07.003. Epub 2018 Aug 3.
7
Clinical analysis of cervical lymph node metastasis risk factors in patients with papillary thyroid microcarcinoma.甲状腺微小乳头状癌颈淋巴结转移危险因素的临床分析。
J Endocrinol Invest. 2019 Feb;42(2):227-236. doi: 10.1007/s40618-018-0908-y. Epub 2018 Jun 6.
8
Risk factors for neck nodal metastasis in papillary thyroid microcarcinoma: a study of 1066 patients.甲状腺微小乳头状癌颈部淋巴结转移的危险因素:一项 1066 例患者的研究。
J Clin Endocrinol Metab. 2012 Apr;97(4):1250-7. doi: 10.1210/jc.2011-1546. Epub 2012 Feb 8.
9
Routine Lateral Level V Dissection May Not Be Necessary for Papillary Thyroid Microcarcinoma With Lateral Lymph Node Metastasis: A Retrospective Study of 252 Cases.对于伴有侧方淋巴结转移的甲状腺微小乳头状癌,常规的Ⅴ区侧方清扫可能并非必要:一项252例病例的回顾性研究
Front Endocrinol (Lausanne). 2019 Aug 20;10:558. doi: 10.3389/fendo.2019.00558. eCollection 2019.
10
Clinical and Ultrasonic Risk Factors for Lateral Lymph Node Metastasis in Papillary Thyroid Microcarcinoma: A Systematic Review and Meta-Analysis.甲状腺微小乳头状癌侧方淋巴结转移的临床及超声危险因素:一项系统评价与Meta分析
Front Oncol. 2020 Apr 3;10:436. doi: 10.3389/fonc.2020.00436. eCollection 2020.

引用本文的文献

1
Machine learning models for diagnosing lymph node recurrence in postoperative PTC patients: a radiomic analysis.用于诊断甲状腺乳头状癌术后患者淋巴结复发的机器学习模型:一项影像组学分析
BMC Cancer. 2025 Aug 12;25(1):1308. doi: 10.1186/s12885-025-14594-y.
2
Nomograms for predicting cervical central lymph node metastases and high-volume cervical central lymph node metastases in papillary thyroid carcinoma.预测甲状腺乳头状癌颈部中央淋巴结转移及高容量颈部中央淋巴结转移的列线图。
Gland Surg. 2025 Mar 31;14(3):421-435. doi: 10.21037/gs-24-237. Epub 2025 Mar 26.
3
Proteomic Analysis of Tissue Proteins Related to Lateral Lymph Node Metastasis in Papillary Thyroid Microcarcinoma.甲状腺微小乳头状癌侧方淋巴结转移相关组织蛋白的蛋白质组学分析
J Proteome Res. 2025 Jan 3;24(1):256-267. doi: 10.1021/acs.jproteome.4c00737. Epub 2024 Nov 27.
4
Serum small extracellular vesicles-derived BST2 as a biomarker for papillary thyroid microcarcinoma promotes lymph node metastasis.血清小细胞外囊泡来源的BST2作为甲状腺微小乳头状癌的生物标志物促进淋巴结转移。
Cancer Gene Ther. 2025 Jan;32(1):38-50. doi: 10.1038/s41417-024-00854-9. Epub 2024 Nov 18.
5
Risk stratification for central lymph node metastasis in mono-focal papillary thyroid carcinoma patients with encapsulated tumor as confirmed by preoperative ultrasound: a multi-center analysis.术前超声证实包膜内单发甲状腺乳头状癌患者中央区淋巴结转移风险分层:多中心分析。
Endocrine. 2024 Dec;86(3):1045-1054. doi: 10.1007/s12020-024-03861-w. Epub 2024 Jul 25.
6
Evaluation of Hematoma Formation after Thyroidectomy Surgery and Its Related Factors.甲状腺切除术后血肿形成及其相关因素的评估
World J Plast Surg. 2024;13(1):37-42. doi: 10.61186/wjps.13.1.37.
7
Clinicopathological Features and Molecular Signatures of Lateral Neck Lymph Node Metastasis in Papillary Thyroid Microcarcinoma.甲状腺微小乳头状癌侧颈部淋巴结转移的临床病理特征和分子特征。
Endocrinol Metab (Seoul). 2024 Apr;39(2):324-333. doi: 10.3803/EnM.2023.1885. Epub 2024 Apr 4.
8
Demographic, clinical, and surgical features of patients undergoing thyroidectomy due to thyroid lesions in Southern Iran: A cross-sectional study.伊朗南部因甲状腺病变接受甲状腺切除术患者的人口统计学、临床和手术特征:一项横断面研究。
Health Sci Rep. 2024 Apr 1;7(4):e2012. doi: 10.1002/hsr2.2012. eCollection 2024 Apr.
9
Preoperative glucose-to-lymphocyte ratio predicts survival in cancer.术前血糖与淋巴细胞比值可预测癌症患者的生存情况。
Front Endocrinol (Lausanne). 2024 Mar 4;15:1284152. doi: 10.3389/fendo.2024.1284152. eCollection 2024.
10
Correlation analysis of risk factors for cervical lymphatic metastasis in papillary thyroid carcinoma.甲状腺乳头状癌颈淋巴结转移危险因素的相关性分析。
Diagn Pathol. 2024 Jan 13;19(1):13. doi: 10.1186/s13000-024-01440-1.

本文引用的文献

1
2015 American Thyroid Association Guidelines for Thyroid Nodules and Differentiated Thyroid Cancer and Their Implementation in Various Care Settings.2015年美国甲状腺协会甲状腺结节和分化型甲状腺癌指南及其在不同医疗环境中的实施
Thyroid. 2016 Feb;26(2):319-21. doi: 10.1089/thy.2015.0530. Epub 2015 Dec 17.
2
Prediction of cervical lymph node metastasis in patients with papillary thyroid cancer using combined conventional ultrasound, strain elastography, and acoustic radiation force impulse (ARFI) elastography.联合应用传统超声、应变弹性成像及声辐射力脉冲(ARFI)弹性成像预测甲状腺乳头状癌患者颈部淋巴结转移
Eur Radiol. 2016 Aug;26(8):2611-22. doi: 10.1007/s00330-015-4088-2. Epub 2015 Nov 11.
3
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.2015年美国甲状腺协会成人甲状腺结节和分化型甲状腺癌管理指南:美国甲状腺协会甲状腺结节和分化型甲状腺癌指南工作组
Thyroid. 2016 Jan;26(1):1-133. doi: 10.1089/thy.2015.0020.
4
Risk factors for central lymph node metastasis in papillary thyroid carcinoma: A National Cancer Data Base (NCDB) study.甲状腺乳头状癌中央淋巴结转移的危险因素:一项国家癌症数据库(NCDB)研究
Surgery. 2016 Jan;159(1):31-9. doi: 10.1016/j.surg.2015.08.032. Epub 2015 Oct 2.
5
Survival from Differentiated Thyroid Cancer: What Has Age Got to Do with It?分化型甲状腺癌的生存:年龄与之有何关系?
Thyroid. 2015 Oct;25(10):1106-14. doi: 10.1089/thy.2015.0104. Epub 2015 Aug 12.
6
Risk Factors for Central Compartment Lymph Node Metastasis in Papillary Thyroid Microcarcinoma: A Meta-Analysis.甲状腺微小乳头状癌中央区淋巴结转移的危险因素:一项Meta分析
World J Surg. 2015 Oct;39(10):2459-70. doi: 10.1007/s00268-015-3108-3.
7
Presence and Number of Lymph Node Metastases Are Associated With Compromised Survival for Patients Younger Than Age 45 Years With Papillary Thyroid Cancer.对于年龄小于 45 岁的甲状腺乳头状癌患者,淋巴结转移的存在和数量与生存受损有关。
J Clin Oncol. 2015 Jul 20;33(21):2370-5. doi: 10.1200/JCO.2014.59.8391. Epub 2015 Jun 15.
8
Ultrasonographic findings relating to lymph node metastasis in single micropapillary thyroid cancer.超声检查结果与单发性微小乳头状甲状腺癌淋巴结转移的关系
World J Surg Oncol. 2014 Aug 28;12:273. doi: 10.1186/1477-7819-12-273.
9
Ultrasound assessment of degrees of extrathyroidal extension in papillary thyroid microcarcinoma.甲状腺微小乳头状癌甲状腺外扩展程度的超声评估
Endocr Pract. 2014 Oct;20(10):1037-43. doi: 10.4158/EP14016.OR.
10
Preoperative assessment of extrathyroidal extension of papillary thyroid carcinoma: comparison of 2- and 3-dimensional sonography.甲状腺乳头状癌甲状腺外侵犯的术前评估:二维与三维超声检查的比较
J Ultrasound Med. 2014 May;33(5):819-25. doi: 10.7863/ultra.33.5.819.

甲状腺微小乳头状癌淋巴结转移的风险预测与临床模型构建

Risk prediction and clinical model building for lymph node metastasis in papillary thyroid microcarcinoma.

作者信息

Lin Dao-Zhe, Qu Ning, Shi Rong-Liang, Lu Zhong-Wu, Ji Qing-Hai, Wu Wei-Li

机构信息

Department of Surgical Oncology, Rui'an People's Hospital, Third Affiliated Hospital of Wenzhou Medical University, Wenzhou.

Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.

出版信息

Onco Targets Ther. 2016 Aug 24;9:5307-16. doi: 10.2147/OTT.S107913. eCollection 2016.

DOI:10.2147/OTT.S107913
PMID:27601922
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5004998/
Abstract

The surgical management of papillary thyroid microcarcinoma (PTMC), especially regarding the necessity of central/lateral lymph node dissection, remains controversial. This study investigated the clinicopathologic factors predictive of lymph node metastasis (LNM) in patients diagnosed with PTMC. Multivariate logistic regression analysis was used for PTMC patients identified from the Surveillance, Epidemiology, and End Results database who were treated by surgery between 2002 and 2012, to determine the association of clinicopathologic factors with LNM. According to the results, a total of 31,017 patients met the inclusion criteria of the study. Final histology confirmed 2,135 (6.9%) cases of N1a disease and 1,684 cases (5.4%) of N1b disease. Our multivariate logistic regression analysis identified variables associated with both central LNM and lateral lymph node metastasis (LLNM), including a younger age (<45 years), male sex, non-Hispanic white and other race, classical papillary histology, larger tumor size, multifocality, and extrathyroidal extension; distant metastasis was also significantly associated with LLNM. The significant predictors identified from multivariable logistic regression were integrated into a statistical model that showed that extrathyroidal extension had maximum weight in the predictive role for LNM. LLNM was validated to be a significant risk factor for cancer-specific death in Cox regression analyses, whereas central LNM failed to predict a worse cancer-specific survival according to our data. Therefore, we suggested that central lymph node dissection could be performed in certain patients with risk factors. Given the prevalence of LLNM in PTMC, a thorough inspection of the lateral compartment is recommended in PTMC patients with risk factors for precise staging; from the viewpoint of a radical treatment for tumors, prophylactic lateral lymph node dissection that aims to remove the occult lateral lymph nodes may be an option for PTMC with risk factors. Multicenter studies with long-term follow-up are recommended to better understand the risk factors and surgical management for cervical nodes in PTMC.

摘要

甲状腺微小乳头状癌(PTMC)的手术治疗,尤其是关于中央/侧方淋巴结清扫的必要性,仍存在争议。本研究调查了诊断为PTMC的患者中预测淋巴结转移(LNM)的临床病理因素。对2002年至2012年间在监测、流行病学和最终结果数据库中识别出的接受手术治疗的PTMC患者进行多因素逻辑回归分析,以确定临床病理因素与LNM的关联。结果显示,共有31,017例患者符合研究纳入标准。最终组织学确诊2,135例(6.9%)N1a期疾病和1,684例(5.4%)N1b期疾病。我们的多因素逻辑回归分析确定了与中央LNM和侧方淋巴结转移(LLNM)均相关的变量,包括年龄较小(<45岁)、男性、非西班牙裔白人和其他种族、经典乳头状组织学、肿瘤较大、多灶性和甲状腺外侵犯;远处转移也与LLNM显著相关。从多变量逻辑回归中确定的显著预测因素被整合到一个统计模型中,该模型显示甲状腺外侵犯在LNM的预测作用中权重最大。在Cox回归分析中,LLNM被证实是癌症特异性死亡的显著危险因素,而根据我们的数据,中央LNM未能预测更差的癌症特异性生存。因此,我们建议在某些有危险因素的患者中可进行中央淋巴结清扫。鉴于PTMC中LLNM的发生率,建议对有危险因素的PTMC患者进行侧方区域的彻底检查以进行精确分期;从肿瘤根治性治疗的角度来看,旨在切除隐匿性侧方淋巴结的预防性侧方淋巴结清扫可能是有危险因素的PTMC的一种选择。建议进行长期随访的多中心研究,以更好地了解PTMC颈部淋巴结的危险因素和手术治疗。